Some Information about Complex Care of Drug Addicts during Five-Year Duration of Methadone Maintenance Program in General Faculty Hospital in Prague;Některé Poznatky z Komplexní Péče o Drogově Závislé za 5 Roků Činnosti Metadonového Centra ve VFN Praha

Vnitrni Lekarstvi

Volumn 49, Issue 11, 2003, Pages 851-858

  Popov, Petr ^a   Becka J ^a   Wilczek, H ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Buprenorphine; Health care; Maintenance program; Methadone; Psychiatric care; Social care

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

ARTICLE; GENERAL HOSPITAL; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; LONGITUDINAL STUDY; MENTAL HEALTH CARE; METHADONE TREATMENT; OPIATE ADDICTION; PSYCHOPHARMACOLOGY; PUBLIC HEALTH SERVICE; SOCIAL CARE;

ADULT; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 0344445376     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Drugs in focus (January - February 2002). Key role of substitution in drug treatment, European Monitoring Centre for Drug and Drug Addiction (EMCDDA), Lisbon, 2002
2. Reviewing current practice in drug-substitution treatment in the European Union. European Monitoring Centre for Drug and Drug Addiction (EMCDDA) Insights series No 3, Office for Official Publications of the European Communities, Luxembourg, 2000
3. Farrell, M. et al.: Substance misuse and psychiatric comorbidity; an overview of the OPCS national psychiatric morbidity survey. Addictive Behaviours, 23, 6, 1998, 909-918, Elsevier Science Ltd, Oxford
4. Popov, P.: Metadonová substituční léčba v České republice. Adiktologie, 2, 1, SCAN Tišnov 2002, 25-31
5. Kreek, M. J.: Plasma and urine levels of methadone. NY State J. Med. 1973; 2773-2777
6. Loimer, N., Schmid, R.: The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend. 1992; 30 (3): 241
7. Loimer, N. et al.: Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels. Psychopharmacology (Berl.), 1991; 103 (4): 538
8. Dole, V. P.: Implications of methadone maintenance for theories of narcotic addiction. JAMA, 1988; 260: 3025-3029
9. Kreek, M. J.: Medical complications in methadone patients. Ann. NY Acad. Sci., 1978; 311: 29, 110-134
10. Ball, J. C., Ross, A.: The effectiveness of methadone maintenance treatment. New York: Springer-Verlag, 1991
11. Senay, E.C.: Withdrawal from methadone maintenance. Arch. Gen. Psych., 1977; 34, 361-367
12. Caplehorn, J. R. M., Bell, J.: Methadone dosage and retention of patients in maintenance treatment. Med. J. Aust., 1991; 154: 195-199
13. Lowinson, J.H. et al.: Methadone maintenance. In: Lowinson, J. H., Ruiz, P., Millman, R. B. et al.: Substance abuse: A comprehensive textbook. 3rd ed. Williams & Wilkins, Baltimore, 1997; 405-415
14. Standard substituční léčby. Metodické opatření. Věstník Ministerstva zdravotnictví České republiky; ročník 2001, částka 4
15. Marsden, J. Gossop, M., Steward, D. et al.: Psychiatric symptoms among clients seeking treatment for drug dependence. Br. J. Psychiatry, 2000; 176: 285-289
16. Milby, J. B. et al.: Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am. J. Drug Alcohol Abuse, 1996; 22: 95-107
17. Pani, P. P., Trogu, E., Conti, P. et al.: Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997; 48: 119-126
18. Ward, J., et al.: Methadone maintenance therapy. CNS Drugs, 6, 1996, 440-449
19. Bertschy, G.: Methadone maintenance treatment. Eur. Arch. Psych. Clin. Neurosci., 245, 1995, 114-124
20. Kreek, M. J.: Opioid receptors. Neurochem. Res. 21, 1996, 469-488
21. Methadone treatment for opioid dependence. Ed. Strain, E. C., Stitzer, M. L., Baltimore. J. Hopkins Univ. Press, 1999
22. Novick, D. M., Richman, B. L., Friedman, J. M. et al.: The medical status of methadone maintenance patients in treatment for 11-18 years. Drug Alc. Dep., 33, 1993, 235-245
23. Torrens, M., San, L., Martinez, A. et al.: Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 92, 1997, 707-715
24. Strain, E. C. et al.: The effects of buprenorphine in buprenorphine maintained volunteers. Psychopharmacol. 129, 1997, 329-338
25. Caplehorn, J. R. M., Lumley, T. S., Irwing, L.: Staff attitudes and retention of patients in methadone maintenance programs. Drug Alc. Dep. 52, 1998, 57-61
26. Wilczek, H.: Problematika substituční léčby závislosti na opiátech a klinický význam metadonu. Čas. Lék. čes., 137, 1998, 725-728
27. Wilczek, H., Holakovský, J., Kovářová, Š. et al.: Stomatologická ošetření celkové anestezii u pacienta v metadonovém programu. Česká stomatologie, 2, 1999, 45-48
28. Wilczek, H.: Lze léčit narkomany? Trendy v medicině, 3, 2000, 48-55
29. Wilczek, H., Veselý, Z., Pesl, F.: Pilotní studie k dlouhodobému sledování zdravotního stavu abuzérů závislých na opiátech léčených metadonem. Čas. Lék. čes. 141, 2002, 393-397
30. Wilczek, H.: Nemocný toxikoman. Addiktologie. 2, 2002, 53-61
31. Popov, P.: Editorial. Adiktologie 2, 2002, 3-5
32. Tidane, L., Riglietta, M., Camprua, M.: Methadone treatment. Heroin Add. Rel. Clin. Probl. 3, 2001, 45-47
33. Coppel, A., Block-Laine, J. F., Charpak, Y. et al.: Evaluation survey of a methadone treatment share are programme between a special clinic and a network of general practitioner. Heroin Add. Rel. Chnic Probl., 3, 2001, 21-28
34. Wilczek, H., Urbánek, P.: Prevalence virových infekcí jater u drogově závislých osob léčených v pražském metadonovém centru. Do tisku Cas. Lék. čes., 2002
35. Brown, H. L., Britton, K. A., Mahaffey, D. et al.: Methadone maintenance in pregnancy. Am. J. Obstet. Gynecol. 179, 1998, 459-463
36. Hwang, L. Y., Ross, M. W., Zack, C. et al.: Prevalence of Sexual Transmitted Infections and Associated Risk Factors among Population of Drug Abusers. Clin. Inf. Dis., 31, 2000, 920-926